Sign In
Buy IMNN
$2.10
-0.0400 (-1.87%)
At Close: Jun 03, 2026
Data show d ose - dependent suppression of immun e- suppressive agents
OVATION 2 Study is 50% Enrolled; Excellent R0 Surgical Resection Noted
3 Biopharma Penny Stocks That Could be Millionaire Makers
06:00am, Tuesday, 06'th Jul 2021
These three biotech penny stocks all have developed drugs that have shown strong indications of success. The post 3 Biopharma Penny Stocks That Could be Millionaire Makers appeared first on InvestorPl
Celsion Corporation Establishes Wholly Owned Subsidiary to Manage Investigator-Sponsored Development of ThermoDox®
08:00am, Wednesday, 23'rd Jun 2021
Celsion GmbH will manage current and future cancer studies with Thermo D ox ®
Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank
08:00am, Monday, 21'st Jun 2021
Improvement to the Balance Sheet Leverages Strong Equity Structure
Do Options Traders Know Something About Celsion (CLSN) Stock We Don't?
09:01am, Friday, 11'th Jun 2021
Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
05:00pm, Monday, 07'th Jun 2021
A Quorum Has Been Achieved t o Reconvene Annual Meeting on Thursday June 10, 2021
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
10:11am, Friday, 04'th Jun 2021
49% of S hares V oted, Q uorum N ot E stablished To Hold Annual Meeting
Celsion Corporation Urges All Shareholders to Vote at the 2021 Annual Meeting to be Held on Friday June 4, 2021
08:30am, Thursday, 27'th May 2021
Calls for All Shareholders to Vote so Quorum Requirement t o Hold The Meeting is Met
Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2021 Results - Earnings Call Transcript
01:54pm, Friday, 14'th May 2021
Celsion Corporation (CLSN) CEO Michael Tardugno on Q1 2021 Results - Earnings Call Transcript
Celsion Corporation Reports First Quarter 2021 Financial Results and Provides Business Update
08:00am, Friday, 14'th May 2021
Focus on Immuno-Oncology and Next-Generation Vaccines is Suppor ted with a Strong Balance Sheet
Celsion Corporation to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021
08:30am, Friday, 07'th May 2021
LAWRENCEVILLE, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announce
Top Penny Stocks Today? 3 Cheap Stocks to Watch
10:38am, Monday, 19'th Apr 2021
Penny stocks are in focus once again as the hype around Doge Coin ramps up The post Top Penny Stocks Today? 3 Cheap Stocks to Watch appeared first on Penny Stocks to Buy, Picks, News and Information |
CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING
05:00pm, Monday, 05'th Apr 2021
Lawrenceville, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct
Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates
09:23am, Thursday, 01'st Apr 2021
Celsion Corporation (NASDAQ: CLSN) has announced a poster highlighting its ongoing Phase 1/2 OVATION 2 Study with GEN-1 in advanced ovarian cancer was presented last week at the Virtual Annual Mee
